Table 5

Multivariable analysis of factors associated with in-hospital mortality during admissions for community-acquired pneumonia (CAP), ventilator-associated pneumonia (VAP) and non-ventilator hospital-acquired pneumonia (NV-HAP) among patients with T2DM

CAPVAPNV-HAP
OR (95% CI)OR (95% CI)OR (95% CI)
Female sex1.01 (0.96 to 1.07)1.95 (1.28 to 2.96)1.04 (0.89 to 1.21)
40–64 years111
65–74 years1.5 (1.34 to 1.68)1.58 (1.01 to 2.46)1.45 (1.12 to 1.87)
≥75 years2.91 (2.62 to 3.23)2.55 (1.54 to 4.21)1.96 (1.54 to 2.5)
Myocardial infarction1.98 (1.14 to 3.45)
Congestive heart failure1.25 (1.19 to 1.32)1.21 (1.03 to 1.41)
Peripheral vascular disease1.53 (1.41 to 1.65)1.47 (1.23 to 1.77)
Dementia2.08 (1.94 to 2.23)
COPD0.66 (0.63 to 0.7)2.03 (1.22 to 3.38)
Hemiplegia or paraplegia2.25 (1.8 to 2.82)
Renal disease1.11 (1.05 to 1.18)
Cancer1.97 (1.82 to 2.14)1.33 (1.08 to 1.65)
Moderate/severe liver disease2.07 (1.69 to 2.54)1.61 (1.11 to 2.32)
Metastatic cancer4.87 (4.4 to 5.4)2.33 (1.75 to 3.1)
Axial CT of thorax0.64 (0.56 to 0.72)
Non-invasive mechanical ventilation2.15 (1.88 to 2.46)
Invasive mechanical ventilation4.59 (3.94 to 5.34)
Dialysis2.01 (1.68 to 2.4)2.09 (1.26 to 3.47)1.77 (1.31 to 2.4)
Pressure ulcers2.5 (2.24 to 2.78)1.65 (1.26 to 2.17)
Streptococcus pneumoniae 0.55 (0.49 to 0.61)
Haemophilus influenzae 0.26 (0.16 to 0.41)
Undergone surgery0.62 (0.41 to 0.96)0.73 (0.62 to 0.86)
  • COPD, chronic obstructive pulmonary disease; T2DM, type 2 diabetes mellitus.